Diagnosis and drugs: Help or hindrance when people with learning disabilities have psychologicalproblems?

British Journal of Learning Disabilities

Volumn 29, Issue 1, 2001, Pages 26-33

  Kroese, Biza Stenfert ^a,b   Dewhurst, Damian ^c   Holmes, Guy ^d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Dudley Priority Health NHS Trust   (United Kingdom)

^c Hounslow and Spelthorne Community Mental Health NHS Trust   (United Kingdom)

^d Shropshire's Community and Mental Health Services NHS Trust ^*  (United Kingdom)

Author keywords

Evidence based practice; Learning disabilities; Psychiatric diagnosis; Psychotropic medication

Indexed keywords

EID: 0006008954     PISSN: 13544187     EISSN: 14683156     Source Type: Journal    
DOI: 10.1046/j.1468-3156.2001.00085.x     Document Type: Review

References (63)

1. Aman M.G. & Singh N.N. (1983) Pharmacological intervention. In: Matson J.L., Mulick J.L., editors. Handbook of mental retardation. Oxford, Pergamon Press: 317-337.
2. Aman M.G. & Singh N.N. (1988) Patterns of drug use, methodological considerations, measurement techniques and future trends. In: Aman M.G., Singh N.N., editors. Psychopharmacology of developmental disabilities. Berlin, Springer-Verlag: 1-28.
3. Antaki C. & Rapley M. (1996) Questions and answers to psychological assessment schedules: hidden troubles in 'quality of life' interviews. / Intellectual Disability Res, 40: 421-37.
4. Arscott K., Stenfert Kroese B. & Dagnan D. (2000) A study of the knowledge that People with Intellectual Disabilities have of their Prescribed Medication. JARID, 13: 90-99.
5. Bannister D. (1968) The logical requirements of research into schizophrenia. Br ] Psychiatry, 114: 181-8.
6. Bentall R.P. (1990) The syndromes and symptoms of psychosis. In: Bentall R.P., editor. Reconstructing schizophrenia. London, Routledge: 23-60.
7. Boyle M. (1990) Schizophrenia: a scientific delusion? London, Routledge.
8. Boyle M. (1996) Diagnosis, science and power. Asylum, 10: 16-9.
9. Boyle M. (1999) Diagnosis. In: , Newnes C., Holmes G., Dunn C., editors. This is madness: a critical look at psychiatry and the future of mental health services. Ross-on-Wye, PCCS Books: 75-90.
10. Branford D. (1994) A study of the prescribing for people with learning disabilities living in the community and in National Health Service care. / Intellectual Disability Res, 38: 577-86.
11. Branford D. (1996) A review of antipsychotic drugs prescribed for people with learning disabilities who live in Leicestershire. / Intellectual Disability Res, 40: 358-68.
12. Breggin P.R. (1991) Toxic psychiatry. London, Harper Collins.
13. Briggs R. (1989) Monitoring and evaluating psychotropic drug use for persons with mental retardation: a follow-up report. Am } Mental Retardation, 93: 618-23.
14. British Medical Association and the Royal Pharmaceutical Society of Great Britain (BMA & RPSGB) (1998) British national formulary. London, The Pharmaceutical Press.
15. Casey D.E. & Keepers G.A. (1988) Neuroleptic side effects: acute extra pyramidal syndromes and tardive dyskinesia. In: Casey D.E., Christense A.V., editors. Psychopharmacology: current trends. Berlin, Springer-Verlag: 74-93.
16. Christian L., Snycerski S.M., Singh N.N. & Poling A. (1999) Direct service staff and their perceptions of psychotropic medication in non-institutional settings for people with intellectual disability. / Intellectual Disability Res, 43: 88-93.
17. Chua S.E. & McKenna P.J. (1995) Schizophrenia - a brain disease? Br I Psychiatry, 166: 563-82.
18. Clarke D. (1993) Psychopharmacological approaches to challenging behaviour. In: Fleming I., Stenfert Kroese B., editors. People with learning disability and severe challenging behaviour: new developments in service and therapy. Manchester, Manchester University Press: 211-234.
19. Clarke D.J. (1997) Towards rational psychotropic prescribing for people with learning disability. Br ] Learning Disability, 25: 46-52.
20. Clarke D.J., Kelley S., Thinn K. & Corbett J.A. (1990) Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings. / Mental Deficiency Res, 34: 385-95.
21. Clements J. (1997) Sustaining a cognitive psychology for people with learning disabilities. In: Stenfert Kroese B, Dagnan D., Loumidis K., editors. Cognitive-behavioural therapy for people with learning disabilities. London, Routledge: 162-181.
22. Crabbe H.F. (1994) Pharmacotherapy in mental retardation. In: Bouras N., editor. Mental health in mental retardation: recent advances and practices. Cambridge, Cambridge University Press: 187-204.
23. Crepaz-Keay D. (1999) Drugs. In: Newnes C, Holmes G., Dunn C, editors. This is madness: a critical look at psychiatry and the future of mental health services. Ross-on-Wye, PCCS Books: 91-96.
24. Dartington A. (1996) Where angels fear to tread: idealism, despondency and inhibition of thought in hospital nursing. In: Obholzer A., Zagier Roberts V., editors. The unconscious at work: individual and organizational stress in the human services. London, Routledge: 101-109.
25. Duggan L. & Brylewski J. (1999) Effectiveness of antipsychotic medication in people with intellectual disability and schizophrenia: a systematic review. / Intellectual Disability Res, 43: 94-104.
26. Etherington J., Sheppard L.C., Ballinger B.R. & Fenton G.W. (1995) Psychotropic drugs in a hospital for intellectual disability: the story of 18 years. Mental Handicap Res, 8: 184-93.
27. Fleming I., Caine A., Ahmed S. & Smith S. (1996) Aspects of the use of psychoactive medication among people with intellectual disabilities who have been resettled from long-stay hospitals into dispersed housing. / Appl Res Intellectual Disabilities, 9: 194-205.
28. Fleming I. & Stenfert Kroese B. (1993) People with learning disability and severe challenging behaviour - new developments in services and therapy. Manchester, Manchester University Press.
29. Foucault M. (1961) Madness and civilization. Harmondsworth, Penguin.
30. Fraser W. & Nolan M. (1994) Psychiatric disorders in mental retardation. In: Bouras N., editor. Mental health in mental retardation: recent advances and practices. Cambridge, Cambridge University Press: 79-92.
31. Gedye A. (1998) Neuroleptic-induced dementia documented in four adults with mental retardation. Mental Retardation, 36: 182-6.
32. Glanzer M. & Cunitz A.R. (1966) Two stage mechanisms in free recall. / Verbal Learning Verbal Behavior, 5: 351-60.
33. Gualtieri C.T. (1993) The problem of tardive dyskinesia. Brain Cognition, 23: 102-9.
34. Harper D.C. & Wadsworth J.S. (1993) Behavioral problems and medication utilization. Mental Retardation, 31: 97-103.
35. Healey D. (1993) Psychiatric drugs explained. Guildford, Mosby.
36. Hogg J. (1992) The administration of psychotropic and anticonvulsant drugs to children with profound intellectual disability and multiple impairments. / Intellectual Disability Res, 36: 473-88.
37. Holmes G.R. & Newnes C. (1996) Medication - the holy water of psychiatry. Open Mind, 82: 14-5.
38. Inoue F. (1982) A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons. Mental Retardation, 20: 70-1.
39. James D.H., Mukherjee T. & Smith C. (1996) Schizophrenia and learning disability. Br } Learning Disabilities, 24: 90-4.
40. Kiernan C, Reeves D. & Alborz A. (1995) The use of anti-psychotic drugs with adults with learning disabilities and challenging behaviour. / Intellectual Disability Res, 39: 263-74.
41. Kirman B. (1975) Drug therapy in mental handicap. Br J Psychiatry, 127: 545-9.
42. Larson E.B., Kukull W.A., Buchner D. & Reifler B.V. (1987) Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Medicine, 107: 169-73.
43. Lennox D.B., Miltenberger R.G., Spengler P. & Erfanian N. (1988) Decelerative treatment practices with persons who have mental retardation: a review of five years of literature. Am } Mental Retardation, 92: 492-501.
44. Manchester D. (1993) Neuroleptics, learning disability and the community: some history and mystery. BrMed Journal, 307:184-7.
45. Mansell J. (1994) Challenging behaviour: the prospect for change. Br ] Learning Disabilities, 22: 2-5.
46. Moss S., Prosser H., Costello H., et al. (1998) Reliability and validity of the PAS-ADD Checklist for detecting psychiatric disorders in adults with intellectual disability. / Intellectual Disability Res, 42: 173-83.
47. Moss S., Prosser H., Ibbotson B. & Goldberg D. (1996) Respondent and informant accounts of psychiatric symptoms in a sample of patients with learning disability. / Intellectual Disability Res, 40: 457-65.
48. Ono Y. (1998) Behavior disorders in persons with mental retardation receiving antipsychotic medication. Res Dev Disabilities, 19: 123-30.
49. Pam A. (1995) Biological psychiatry: science or pseudoscience? In: Ross C.A., Pam A., editors. Pseudoscience in biological psychiatry: blaming the body. New York, NY, Wiley: 000-000.
50. Rogers A., Pilgrim D. & Lacey R. (1993) Experiencing psychiatry. London, Mind.
51. Sarbin T. (1990) Toward the obsolescence of the schizophrenia hypothesis. / Mind Behavior, 11: 259-83.
52. Sigelman C.K., Budd E.C., Winer J.L., Schoenrock C.J. & Martin P.W. (1982) Evaluating alternative techniques of questioning mentally retarded persons. Am } Mental Deficiency, 86: 511-8.
53. Slade P. & Bentall R.P. (1988) Sensory deception - a scientific analysis of hallucination. London, Croom Helm.
54. Stenfert Kroese B. (1997) Cognitive-behavioural therapy for people with learning disabilities: conceptual and contextual issues. In: Stenfert Kroese B., Dagnan D., Loumidis K., editors. Cognitive-behavioural therapy for people with learning disabilities. London, Routledge: 1-15.
55. Stenfert Kroese B., Cushway D. & Hubbard C. (1998) The conceptualisation of dreams by people with intellectual disabilities. / Appl Res Intellectual Disabilities, 11: 146-55.
56. Stokes J. (1996) Institutional chaos and personal stress. In: Obholzer A., Zagier Roberts V., editors. The unconscious at work: individual and organizational stress in the human services. London, Routledge: 121-128.
57. Sturmey P., Reed J. & Corbett J. (1991) Psychometric assessment of psychiatric disorders in people with learning difficulties (mental handicap): a review of measures. Psychol Med, 21: 143-55.
58. Sweeney D.P., Forness S.R. & Levitt J.G. (1998) An overview of medications commonly used to treat behavioral disorders associated with autism, Tourette syndrome and pervasive developmental disorders. Focus Autism Other Dev Disorders, 13: 144-50.
59. Turner T.H. (1989) Schizophrenia and mental handicap: an historical review, with implications for further research. Psychological Medicine, 19: 301-14.
60. Turnbull H.R. (1977) Consent procedures. A conceptual approach to protection without overprotection. In: Mittler P., editor. Research to practice in mental retardation: care and intervention, Vol. I. London, University Park Press: 65-70.
61. Weisblatt S.A. (1994) Diagnosis of psychiatric disorders in persons with mental retardation. In: Bouras N., editor. Mental health in mental retardation: recent advances and practices. Cambridge, Cambridge University Press: 93-101.
62. White M.J., Nichols C.N., Cook R.S., Spengler P.M., Walker B.S. & Look K.K. (1995) Diagnostic overshadowing and mental retardation: a meta-analysis. Am } Mental Retardation, 100: 293-8.
63. Wolfensberger W. (1992) A guideline on protecting the health and lives of patients in hospitals, especially if the patient is a member of a societally devalued class. Syracuse, NY, Training Institute for Human Service Planning, Syracuse University.